VivoSight Dx Platform Enhancement & AI Integration

About Michelson Diagnostics

Michelson Diagnostics is a pioneer and world leader in applying Optical Coherence Tomography (OCT) to dermatology through its flagship VivoSight Dx system. The company, founded by a team of physicists and engineers, has established strong clinical validation with its technology cited in hundreds of peer-reviewed publications. It operates as a commercial-stage, revenue-generating private company, targeting both the clinical dermatology and skin research markets with a direct sales and support model. Michelson's strategy centers on deepening the utility of OCT imaging in skin health, from scar assessment to non-melanoma skin cancer management.

Therapeutic Areas